Question special

Given that other comorbid SUDs were established at baseline and taking into consideration that bupropion is effective for tobacco use disorder, naltrexone for alcohol use disorder, and the effect on a stimulant use disorder was being assessed on this study, was the impact of XR-NTX naltrexone and bupropion on these other pathologies evaluated?